About Linearis

English
English

Science-First. Founder-Built. Mission-Driven.

Linearis was founded on a simple conviction: the gap between scientific discovery and patient impact is too wide, and too slow.

Linearis was founded on a simple conviction: the gap between scientific discovery and patient impact is too wide, and too slow.

OUR VISION

Shaping the future of healthcare by harnessing the convergence of AI and life science to enable partnerships and improve outcomes

OUR MISSION

We invest in founders and accelerate innovation in life science through AI to transform healthcare.

OUR VALUES

Build trust in the quality of our data

Create accessible technologies

Innovate for our partners

Maintain integrity and excellence in our work

Have passion for improving people’s health

Tandem Ventures and Labs

Tandem Ventures and Labs

Tandem Ventures and Labs

Tandem Ventures and Labs

Linearis, with its tandem Ventures Fund and Laboratory, is pioneering and supporting discoveries through direct investments in innovative AI-powered life sciences companies

Linearis, with its tandem Ventures Fund and Laboratory, is pioneering and supporting discoveries through direct investments in innovative AI-powered life sciences companies

Drug Discovery

Early Diagnostics

Prevention

Patient Monitoring

Labs

Metabolomic Analysis

Disease Signatures

AI

Our Team

Our Team

The team unites unparalleled, world-renowned experts in AI, biomarker discovery, drug development, biopharma, and healthcare innovation.

The team unites unparalleled, world-renowned experts in AI, biomarker discovery, drug development, biopharma, and healthcare innovation.

Alexandre Le Bouthillier, PhD

Serial entrepreneur in AI (exit @27x)

Angel investor in 15 startups

Board (Mila (honorific), IVADO, Mtl InVivo, MEDTEQ+, QIS, EnvisAGE)

Jacques Corbeil, PhD

Canada Research Chair 
in Medical Genomics + Member MILA

Canadian Senate Medal recipient

Expert in AI + Omics

Manon Boisclair, MS, MBA

Clinician

Global BioPharma exec, commercialized 5 oncology blockbusters

Angel investor in 17 startups

Claudia Carpentier, PhD

Chemical scientist working at the intersection of metabolomics and bioinformatics

Metabolomics analysis for biomarker discovery and clinical research

Advisors

Advisors

Yoshua Bengio, PhD

Modern AI co-father

Mila Founder (World's largest AI research institute)

A.M. Turing Award recipient

David Wishart, PhD

Metabolomics Advisor

David Wishart, PhD

Metabolomics Advisor

Creator of the world human metabolome database

8 metabolomics labs in Canada

Most highly cited scientist in Metabolomics

John Reichenbach, MBA

BioHub / Finance Advisor

John Reichenbach, MBA

BioHub / Finance Advisor

Seasoned Investor in Boston

Founder Harvard Business School - Angel Group

György Marko-Varga PhD

Biomedical Advisor

György Marko-Varga PhD

Biomedical Advisor

Prof. Lund University

European Cancer Moonshot

Lund Prize, Treat for life

Takeshi Bamba PhD

Japan Metabolomic Advisor

Takeshi Bamba PhD

Japan Metabolomic Advisor

Prof. Osaka University

KOL metabolomics

Xavier Fresques PhD

European, UAE AI Advisor

Xavier Fresques PhD

European, UAE AI Advisor

Deputy Director 

Sorbonne Center for AI, Paris & Abu Dhabi

Read Our Latest Publications

Careers

Contact Us